ORAMED PHARM INC's ticker is and the CUSIP is 68403P953. A total of 2 filers reported holding ORAMED PHARM INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7 | -36.4% | 2,800 | -9.7% | 0.00% | – |
| Q2 2023 | $11 | 0.0% | 3,100 | -39.2% | 0.00% | – |
| Q1 2023 | $11 | -88.2% | 5,100 | -34.6% | 0.00% | – |
| Q4 2022 | $93 | -99.7% | 7,800 | +66.0% | 0.00% | – |
| Q3 2022 | $30,000 | +1400.0% | 4,700 | +840.0% | 0.00% | – |
| Q2 2022 | $2,000 | -96.2% | 500 | -91.9% | 0.00% | – |
| Q1 2022 | $53,000 | -60.7% | 6,200 | -34.7% | 0.00% | – |
| Q4 2021 | $135,000 | +3.8% | 9,500 | -3.1% | 0.00% | – |
| Q3 2021 | $130,000 | -0.8% | 9,800 | 0.0% | 0.00% | – |
| Q2 2021 | $131,000 | – | 9,800 | +8421.7% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 115 | +2775.0% | 0.00% | – |
| Q4 2020 | $1,000 | -99.4% | 4 | -98.8% | 0.00% | – |
| Q4 2019 | $166,000 | +3220.0% | 324 | +1805.9% | 0.00% | – |
| Q3 2019 | $5,000 | +400.0% | 17 | +325.0% | 0.00% | – |
| Q2 2019 | $1,000 | -66.7% | 4 | -60.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 10 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | +300.0% | 10 | +11.1% | 0.00% | – |
| Q1 2016 | $1,000 | – | 9 | +80.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 5 | +150.0% | 0.00% | – |
| Q4 2014 | $1,000 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 26,300 | $316,389 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 7,800 | $93 | 0.00% |
| JANE STREET GROUP, LLC | 29,900 | $359,697 | 0.00% |